跳至主要内容
临床试验/CTRI/2020/03/024089
CTRI/2020/03/024089尚未招募不适用

A Randomised controlled parallel group clinical study to evaluate Kushtanashana rasa and panchatiktha ghritha guggulu with Kutaja patra suryapaki taila external application in the management of Eka Kushta w.s.r to Psoriasis

Dr Supreetha M1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年3月23日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Reduction in PASI Scale score

研究概览

简要总结

Psoriasis is one of the most common skin disease which has no permanent cure available.The current treatment modalities available are palliative lotions,ointments and PUVA (Psoralin Ultra Violet A) and Biologic injections which are very expensive and is recommended for long period of time. Psoriasis is having high recurrance rate and often the patient with Psoriasis experience diminished quality of life. Hence there is a need to contribute with safe and effective remedy for its treatment.

Hypothesis:

Null Hypothesis-H0 :The efficacy of Kushtanashana Rasa in the mangement of Eka kushta w.s.r to Psoriasis is insignificant.

Research Hypothesis- H1 :1. The efficacy of Kushtanashana Rasa in the management of Eka kushta w.s.r to Psoriasis is significant.

  1. The efficacy of Kushtanashana Rasa in the management of Eka kushta w.s.r to Psoriasis is significant in comparison to control groups.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.With classical signs and symptoms of Eka Kushta.
  • Presenting with signs and symptoms of Psoriasis.
  • The Subjects willing to give informed consent for research.

排除标准

  • 1.Subjects aged <21 years and > 60 years of age .
  • 2.Subjects suffering from complications of Psoriasis like Psoriatic arthritis .
  • 3.Subjects suffering from Non–psoriatic conditions of skin, IHD, Immune compromised patients and other uncontrolled systemic diseases.
  • 4.Disease which interferes with the course of disease and treatment.
  • 5.Pregnant and Lactating women.

结局指标

主要结局

Reduction in PASI Scale score

时间窗: 16th day,32nd day,49th day and 65th day

次要结局

  • Reduction in DLQI scale score(16th day,32nd day,49th day and 65th day)

研究者

发起方
Dr Supreetha M
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验